Article

As humanity sets its sights on Mars, researchers in Europe and the United States are investigating the feasibility of inducing a state of hibernation, known as torpor, in astronauts during deep-space missions. This concept aims to significantly reduce metabolic activity, thereby lowering heart rates and body temperatures, which could minimize resource requirements for food, water, and oxygen, while also shielding astronauts from radiation and microgravity effects.

Dr. Alexander Chouker from Ludwig Maximilian University of Munich, in collaboration with the European Space Agency (ESA), emphasizes the potential cost-effectiveness of this approach, noting that every kilogram launched into space incurs a high expense. ESA has initiated studies on hibernation pods that could keep astronauts in torpor for the majority of a trip to Mars, which would typically last seven to ten months.

Current research heavily focuses on animal models, such as mice and hamsters, which naturally enter torpor under specific environmental conditions. While promising, the translation of these findings to humans presents challenges, particularly regarding the physiological changes and their impact on brain function.

Experts like Dr. Vladyslav Vyazovskiy stress the necessity of understanding these implications before proceeding with human trials.

US-based SpaceWorks Enterprises has also engaged in this field, receiving NASA grants to explore hibernation habitats. CEO Dr. John Bradford highlights the complexity of inducing a low metabolic state through pharmacological interventions, which would require extensive human testing before application in space.

In conclusion, while substantial hurdles remain, the pursuit of synthetic hibernation represents a potentially transformative leap for human space exploration, offering not only solutions for interplanetary travel but also promising applications in terrestrial healthcare.